Expert consensus statement for periprocedural anticoagulation and antiplatelet therapy in elective bronchoskopy
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F16%3A33159326" target="_blank" >RIV/61989592:15110/16:33159326 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Expert consensus statement for periprocedural anticoagulation and antiplatelet therapy in elective bronchoskopy
Original language description
This procedure is designed to minimize the risk of bleeding and thromboembolic complications in periprocedurálním period endoscopic procedure. For this reason, it is appropriate to divide patients into groups with low, medium and high risk of thromboembolism (TE) and endoscopic procedures into groups with low and high risk of bleeding. Generally speaking, with increase of risk which has to be the lowest limit or shortest discontinuation of anticoagulant therapy. On the other hand, with a growing risk of bleeding because power is necessary to extend the period during which anticoagulant therapy is discontinued. An important parameter is also the time of thromboembolic episodes until the planned performance. Patients with a history of venous thromboembolism elective surgery should not be performed in the first three months after the attack of TEN. In patients with thromboembolic complications of atrial fibrillation (AF) is the most risky first month of the documentation TE complications and elective surgery should be postponed to as late as possible dates. The procedure shows recommendations regarding the withdrawal and re-deployment of anticoagulant and antithrombotic therapy in patients progressing bronchoscopic examination. Below are possible laboratory methods for monitoring the effectiveness of anticoagulant and antiplatelet therapy on coagulation system and possible methods of therapy eventual periprocedurálního bleeding due to anticoagulation or antiplatelet therapy.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FC - Pneumology
OECD FORD branch
—
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2016
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Cor et Vasa
ISSN
0010-8650
e-ISSN
—
Volume of the periodical
58
Issue of the periodical within the volume
1
Country of publishing house
CZ - CZECH REPUBLIC
Number of pages
6
Pages from-to
175-180
UT code for WoS article
—
EID of the result in the Scopus database
—